Ultrasound-stimulated phase-change contrast agents for sonothrombolysis
Ended Project Grant Awarded Last action
- Award ID
- R43HL152819
- Recipient
-
Microvascular Therapeutics Inc. UEI ZA54X6LR5AS3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $378,190
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Arizona, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $378,190 |
Quick answers
Who received award R43HL152819?
R43HL152819 was awarded to Microvascular Therapeutics Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on July 17, 2020.
How much is award R43HL152819 worth?
$378,190 has been obligated on R43HL152819.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award